# The investment follows praise from drugmakers including AstraZeneca for a U.S.-UK agreement aimed at increasing medicine prices in Britain.

*biotech · news · 2026-04-29 · Reuters*

## Key points

- AstraZeneca is investing 300 million pounds in UK life sciences due to a new US-UK deal.
- The investment will complete the Rosalind Franklin building and develop a 'lab of the future' in Cambridge.
- The US-UK agreement will align UK medicine prices with US most-favored-nation pricing policies.
- The investment is expected to secure 1,000 jobs in Cambridge and Macclesfield.

**Companies:** AstraZeneca
**Countries:** United Kingdom, United States

[Read the full story on Reuters](https://www.reuters.com/business/healthcare-pharmaceuticals/astrazeneca-make-405-million-investment-britain-pm-starmer-says-2026-04-29/)

---

Canonical: https://newsio.io/n/3d06ecd3-2b4e-40e1-9bbf-67e48c6d28a3/the-investment-follows-praise-from-drugmakers-including-astrazeneca-for-a-u-s-uk
Summarized by Newsio from Reuters. https://newsio.io/how-it-works